Clinical implication of PRAME immunohistochemistry in differentiating melanoma in situ and dysplastic nevus in non‐acral nevus‐associated melanoma in situ: An institutional experience and meta‐analysis

Documenti analoghi

• Ancillary immunohistochemistry testing for loss of p16 in melanoma: A systematic review and meta‐analysis of diagnostic accuracy studies
  di: Shruti S. Chinchanikar, et al.
  Pubblicazione: (2024)
• Evaluation of PRAME immunohistochemistry in cutaneous vascular neoplasms reveals frequent expression in primary and post‐irradiation cutaneous angiosarcomas
  di: Andrea Krajisnik, et al.
  Pubblicazione: (2024)
• Onychomatricoma is not a subtype of superficial acral fibromyxoma: Can immunohistochemistry help in the differential diagnosis?
  di: Christophe Perrin, et al.
  Pubblicazione: (2024)
• PIK3CA mutation status in apocrine carcinoma arising in apocrine gland hyperplasia/apocrine nevus: A study of four cases
  di: Keisuke Goto, et al.
  Pubblicazione: (2024)
• Incidental detection of non‐melanoma neoplasms in sentinel lymph node biopsy for melanoma staging: A retrospective case series
  di: Meghana Agni, et al.
  Pubblicazione: (2024)